TW285640B - - Google Patents

Info

Publication number
TW285640B
TW285640B TW083105008A TW83105008A TW285640B TW 285640 B TW285640 B TW 285640B TW 083105008 A TW083105008 A TW 083105008A TW 83105008 A TW83105008 A TW 83105008A TW 285640 B TW285640 B TW 285640B
Authority
TW
Taiwan
Prior art keywords
pct
sec
date
pub
date jun
Prior art date
Application number
TW083105008A
Other languages
English (en)
Chinese (zh)
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW285640(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of TW285640B publication Critical patent/TW285640B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
TW083105008A 1993-06-28 1994-06-01 TW285640B (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
TW285640B true TW285640B (enExample) 1996-09-11

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083105008A TW285640B (enExample) 1993-06-28 1994-06-01

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269L (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
CN1074918C (zh) 2001-11-21
EE03205B1 (et) 1999-08-16
GR970300013T1 (en) 1997-05-31
WO1995000148A1 (en) 1995-01-05
CA2165446A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
ES2099048T1 (es) 1997-05-16
NZ268110A (en) 1999-06-29
DE69430427T2 (de) 2002-11-14
DE706395T1 (de) 1997-09-04
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
FI956269A7 (fi) 1995-12-27
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
US5834489A (en) 1998-11-10
NO955313L (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
ATE216237T1 (de) 2002-05-15
FI956269A0 (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
PH31258A (en) 1998-06-18
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
BR9406865A (pt) 1996-03-26
IL110006A (en) 1999-01-26
LT3449B (en) 1995-10-25
CA2165446C (en) 2005-07-05
SA94150010B1 (ar) 2006-04-04
RU2152215C1 (ru) 2000-07-10
AU692161B2 (en) 1998-06-04
US5670524A (en) 1997-09-23
SK164695A3 (en) 1996-07-03
LTIP1958A (en) 1995-01-31
IS4174A (is) 1994-12-29
MY119360A (en) 2005-05-31
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
EP0706395B1 (en) 2002-04-17
AU7086694A (en) 1995-01-17
DE69430427D1 (de) 2002-05-23
PL175518B1 (pl) 1999-01-29
NO955313D0 (no) 1995-12-27
JP3725541B2 (ja) 2005-12-14
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
HUT75115A (en) 1997-04-28
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
CA2186260A1 (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
IL110189A0 (en) New pharmaceutical formulation
IL113631A0 (en) New antagonist compounds
CA2235747A1 (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
IL110006A0 (en) New use of ropivacaine
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
AU6053496A (en) The use of sertraline to treat post myocardial infarction patients
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
GR3021604T3 (en) Application of riluzole as a radiorestorer.
UA29449C2 (uk) N-заміщені похідні 3-азабіцикло[3.2.0]гептану

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees